JP2012229264A5 - - Google Patents

Download PDF

Info

Publication number
JP2012229264A5
JP2012229264A5 JP2012167155A JP2012167155A JP2012229264A5 JP 2012229264 A5 JP2012229264 A5 JP 2012229264A5 JP 2012167155 A JP2012167155 A JP 2012167155A JP 2012167155 A JP2012167155 A JP 2012167155A JP 2012229264 A5 JP2012229264 A5 JP 2012229264A5
Authority
JP
Japan
Prior art keywords
compound
composition
diarrhea
formula
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012167155A
Other languages
English (en)
Japanese (ja)
Other versions
JP5825217B2 (ja
JP2012229264A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012167155A priority Critical patent/JP5825217B2/ja
Priority claimed from JP2012167155A external-priority patent/JP5825217B2/ja
Publication of JP2012229264A publication Critical patent/JP2012229264A/ja
Publication of JP2012229264A5 publication Critical patent/JP2012229264A5/ja
Application granted granted Critical
Publication of JP5825217B2 publication Critical patent/JP5825217B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012167155A 2012-07-27 2012-07-27 18員大環状化合物及びその類似化合物 Expired - Lifetime JP5825217B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012167155A JP5825217B2 (ja) 2012-07-27 2012-07-27 18員大環状化合物及びその類似化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012167155A JP5825217B2 (ja) 2012-07-27 2012-07-27 18員大環状化合物及びその類似化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007553073A Division JP5166040B2 (ja) 2005-01-31 2005-01-31 18員大環状化合物及びその類似化合物

Publications (3)

Publication Number Publication Date
JP2012229264A JP2012229264A (ja) 2012-11-22
JP2012229264A5 true JP2012229264A5 (enExample) 2013-05-09
JP5825217B2 JP5825217B2 (ja) 2015-12-02

Family

ID=47431109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012167155A Expired - Lifetime JP5825217B2 (ja) 2012-07-27 2012-07-27 18員大環状化合物及びその類似化合物

Country Status (1)

Country Link
JP (1) JP5825217B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH065185B2 (ja) 1985-10-30 1994-01-19 鎮▲かく▼ 東島 分力計測方法および装置
JP5935853B2 (ja) * 2014-09-30 2016-06-15 株式会社明電舎 ダイナモメータシステムの制御装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds

Similar Documents

Publication Publication Date Title
JP2015078230A5 (enExample)
JP2012255026A5 (enExample)
HRP20171961T1 (hr) Kemijski spojevi
JP2013032389A5 (enExample)
JP2014507482A5 (enExample)
CY1115959T1 (el) 2-αμινοβενζιμιδαζολο-5-καρβοξαμιδιο ως αντι-φλεγμονωδεις παραγοντες
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
IL218598A (en) Oral solid dosage form containing nanoparticles and process for preparation using gelatin from fish
HRP20180237T4 (hr) Metode za liječenje hcv-a
JP2011105738A5 (enExample)
MD20140073A2 (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
JP2011518833A5 (enExample)
CL2013000677A1 (es) Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn.
UA111972C2 (uk) Вагінальна таблетка, яка містить рифаксимін, спосіб її виготовлення та застосування для лікування вагінальних інфекцій
JP2014205701A5 (enExample)
MX2014011787A (es) Formulaciones farmaceuticas que comprenden antagonistas de ccr3.
MX383411B (es) Limpiador de horno de dosis unitaria de tableta sólida.
EP2810659A4 (en) MOUTH-CATCHING TABLET WITH GRANULATE TO COVER THE BITTER TASTE
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
PT2389070E (pt) Formulações desintegráveis de carbonato de lantânio
FI3509595T3 (fi) Hydroksipyridonaattiaktinidi-/lantanididekorporaatioaineiden formulaatioita
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
IN2013MU02911A (enExample)
JP2014062109A5 (enExample)